"Prescription Drugs" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that cannot be sold legally without a prescription.
| Descriptor ID |
D055553
|
| MeSH Number(s) |
D26.670
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Prescription Drugs".
Below are MeSH descriptors whose meaning is more specific than "Prescription Drugs".
This graph shows the total number of publications written about "Prescription Drugs" by people in this website by year, and whether "Prescription Drugs" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 1 | 0 | 1 |
| 2009 | 2 | 0 | 2 |
| 2010 | 0 | 1 | 1 |
| 2011 | 3 | 2 | 5 |
| 2012 | 2 | 0 | 2 |
| 2014 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 1 | 1 | 2 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 2 | 0 | 2 |
| 2020 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prescription Drugs" by people in Profiles.
-
Prevalence of potential interactions of medications, including herbs and supplements, before, during, and after chemotherapy in patients with breast and prostate cancer. Cancer. 2021 06 01; 127(11):1827-1835.
-
Differences in the Receipt of Low-Value Services Between Publicly and Privately Insured Children. Pediatrics. 2020 02; 145(2).
-
Patient-provider communications about pharmacogenomic results increase patient recall of medication changes. Pharmacogenomics J. 2019 12; 19(6):528-537.
-
Analysis of comprehensive pharmacogenomic profiling to impact in-hospital prescribing. Pharmacogenet Genomics. 2019 02; 29(2):23-30.
-
Prescription Medication Use Among Children and Adolescents in the United States. Pediatrics. 2018 09; 142(3).
-
Association of Prescription Drug Price Rebates in Medicare Part D With Patient Out-of-Pocket and Federal Spending. JAMA Intern Med. 2017 08 01; 177(8):1185-1188.
-
Pharmacy accessibility and cost-related underuse of prescription medications in low-income Black and Hispanic urban communities. J Am Pharm Assoc (2003). 2017 Mar - Apr; 57(2):162-169.e1.
-
Capsule Commentary on Wolf et al., A Patient-Centered Prescription Drug Label to Promote Appropriate Medication Use and Adherence. J Gen Intern Med. 2016 12; 31(12):1507.
-
So Prescription Opioid Disorders are a $78.5 Billion Problem. Med Care. 2016 10; 54(10):899-900.
-
Prescription Trends-Brand-name Drugs vs Generic. JAMA Intern Med. 2016 10 01; 176(10):1573-1574.